GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Agilon Health Inc (NYSE:AGL) » Definitions » Beneish M-Score

Agilon Health (Agilon Health) Beneish M-Score : -1.31 (As of Apr. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Agilon Health Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.31 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Agilon Health's Beneish M-Score or its related term are showing as below:

AGL' s Beneish M-Score Range Over the Past 10 Years
Min: -2.28   Med: -1.88   Max: -1.31
Current: -1.31

During the past 5 years, the highest Beneish M-Score of Agilon Health was -1.31. The lowest was -2.28. And the median was -1.88.


Agilon Health Beneish M-Score Historical Data

The historical data trend for Agilon Health's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agilon Health Beneish M-Score Chart

Agilon Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
- - -2.28 -1.88 -1.31

Agilon Health Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.88 -1.72 -1.75 -1.73 -1.31

Competitive Comparison of Agilon Health's Beneish M-Score

For the Medical Care Facilities subindustry, Agilon Health's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Agilon Health's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Agilon Health's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Agilon Health's Beneish M-Score falls into.



Agilon Health Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Agilon Health for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0591+0.528 * 2.8889+0.404 * 1.0004+0.892 * 1.8074+0.115 * 0.9135
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.7609+4.679 * -0.086581-0.327 * 1.7076
=-1.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $942 Mil.
Revenue was 815.504 + 1215.66 + 1149.052 + 1136.147 = $4,316 Mil.
Gross Profit was -95.296 + 30.477 + 57.193 + 77.296 = $70 Mil.
Total Current Assets was $1,480 Mil.
Total Assets was $1,741 Mil.
Property, Plant and Equipment(Net PPE) was $41 Mil.
Depreciation, Depletion and Amortization(DDA) was $20 Mil.
Selling, General, & Admin. Expense(SGA) was $286 Mil.
Total Current Liabilities was $977 Mil.
Long-Term Debt & Capital Lease Obligation was $43 Mil.
Net Income was -230.433 + -31.436 + -16.749 + 16.022 = $-263 Mil.
Non Operating Income was -1.179 + 20.349 + 15.687 + 9.472 = $44 Mil.
Cash Flow from Operations was -61.166 + -13.018 + -21.204 + -60.811 = $-156 Mil.
Total Receivables was $492 Mil.
Revenue was 369.783 + 694.858 + 670.134 + 653.445 = $2,388 Mil.
Gross Profit was 9.07 + 25.912 + 33.914 + 42.464 = $111 Mil.
Total Current Assets was $1,451 Mil.
Total Assets was $1,697 Mil.
Property, Plant and Equipment(Net PPE) was $32 Mil.
Depreciation, Depletion and Amortization(DDA) was $14 Mil.
Selling, General, & Admin. Expense(SGA) was $208 Mil.
Total Current Liabilities was $535 Mil.
Long-Term Debt & Capital Lease Obligation was $48 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(942.461 / 4316.363) / (492.364 / 2388.22)
=0.218346 / 0.206164
=1.0591

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(111.36 / 2388.22) / (69.67 / 4316.363)
=0.046629 / 0.016141
=2.8889

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1480.076 + 40.987) / 1740.866) / (1 - (1451.274 + 31.953) / 1697.468)
=0.126261 / 0.126212
=1.0004

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=4316.363 / 2388.22
=1.8074

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(13.772 / (13.772 + 31.953)) / (20.161 / (20.161 + 40.987))
=0.301192 / 0.329708
=0.9135

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(285.76 / 4316.363) / (207.789 / 2388.22)
=0.066204 / 0.087006
=0.7609

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((43.213 + 977.156) / 1740.866) / ((47.573 + 535.091) / 1697.468)
=0.586127 / 0.343255
=1.7076

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-262.596 - 44.329 - -156.199) / 1740.866
=-0.086581

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Agilon Health has a M-score of -1.31 signals that the company is likely to be a manipulator.


Agilon Health Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Agilon Health's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Agilon Health (Agilon Health) Business Description

Traded in Other Exchanges
N/A
Address
6210 E. US Highway 290, Suite 450, Austin, TX, USA, 78723
Agilon Health Inc is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. The company enables physicians to create their own Medicare-centric globally capitated line of business.
Executives
Jeffrey A. Schwaneke director C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Steven Sell director, officer: CEO & President C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Benjamin Shaker officer: Chief Markets Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Timothy Gertsch officer: Chief Accounting Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Silvana Battaglia director 227 WASHINGTON STREET, CONSHOHOCKEN PA 19428
Cd&r Investment Associates Ix, Ltd. 10 percent owner MAPLES CORPORATE SERVICES LIMITED, UGLAND HOUSE, GRAND CAYMAN E9 KY101194
Veeral Desai officer: Chief Strategy & Dev. Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Benjamin Kornitzer officer: Chief Med. & Quality Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
John William Wulf director C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Diana Mckenzie director METLIFE, 200 PARK AVENUE, NEW YORK NY 10166
Priscilla Kasenchak officer: Chief Accounting Officer 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Michael L Smith director C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723
Theodore Halkias officer: Chief Business Officer C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831
Joan Danieley officer: Chief Administrative Officer C/O AGILON HEALTH, INC., 1 WORLD TRADE CENTER, SUITE 2000, LONG BEACH CA 90831
Glenn Sobotka officer: Chief Accounting Officer C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN TX 78723